| P2093 | author name string | C Hamers | |
| | S Rehbein | |
| | M Blanchet | |
| | C Cariou | |
| | P Hudelet | |
| | S Goutebroze | |
| | B Lapostolle | |
| | M Duboeuf | |
| P2860 | cites work | Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep | Q45835213 |
| | Protective efficacy of virus-like particles for bluetongue disease | Q45880426 |
| | The re-emergence of bluetongue. | Q52599598 |
| | Assessing the risk of windborne spread of bluetongue in the 2006 outbreak of disease in northern Europe. | Q52675863 |
| | Re-emergence of bluetongue in northern Europe in 2007 | Q81407111 |
| | Bluetongue around the Mediterranean in 2001 | Q95800839 |
| | The epidemiology of bluetongue | Q99360477 |
| | Bluetongue Epidemiology in the European Union | Q27487093 |
| | Will bluetongue come on the wind to the United Kingdom in 2007? | Q31107804 |
| | Culicoides biting midges: their role as arbovirus vectors | Q33889700 |
| | Bluetongue virus in the Mediterranean Basin 1998-2001. | Q34930324 |
| | Recombinant virus vaccine for bluetongue disease in sheep | Q36805280 |
| | Bluetongue in the United Kingdom and northern Europe in 2007 and key issues for 2008. | Q37104489 |
| | The epidemiology of bluetongue | Q39023012 |
| | The transmission and geographical spread of African horse sickness and bluetongue viruses. | Q39243358 |
| | Vaccines against bluetongue in Europe. | Q40440398 |
| | Vaccines for bluetongue | Q41190029 |
| | Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle | Q43654853 |
| | Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep | Q45410795 |
| | Differentiation between field and vaccine strain of bluetongue virus serotype 16. | Q45416492 |
| | Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. | Q45484752 |
| | Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. | Q45757776 |
| | Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. | Q45782124 |
| | Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. | Q45796446 |
| | Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies | Q45820997 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2789-2793 | |
| P577 | publication date | 2009-03-10 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep | |
| P478 | volume | 27 | |